IL-17 A correlates with disease progression in papillary thyroid carcinoma

Background Cancer progression can be promoted by chronic inflammation.

Local immune response may be associated with favourable or unfavourable prognosis of Papillary Thyroid Carcinoma (PTC).

Regulatory T (Treg) cells and T helper 17 (Th17) cells exert opposing function and their balance may have a vital role in promotion of tumor growth.

Treg cells in tumor microenvironment (TME) may promote tumor progression and reduced survival of patients.

Whereas, Th17 cells can promote or inhibit tumor progression depending on phenotypic characteristics of tumor.

In this study, we aimed to analyse the kind of immune response developed and its prognostic impact in future therapeutics.

Methods Cytometric Bead Array (CBA) analysis of pro and anti-inflammatory cytokines (IFN-gamma, IL-2, IL-6, IL-17 A, TNF-alpha and IL-4, IL-10) was done in 15 PTC irrespective of Lymphocytic Thyroiditis (LT) and 16 Hashimoto’s Thyroiditis (HT) cases.

Immunohistochemical expression of FoxP3 and IL-17 A was studied in 27 cases of PTC with LT. Whereas, quantitative gene expression of both was analysed in 10 cases.

Results All the pro-inflammatory cytokines showed mild elevation in PTC with LT.

On IHC, IL-17 A expression was observed in 74% PTC with LT. Whereas, FoxP3 was present in only 40% cases.

Also, IL-17 A expression was significantly associated with age group (> 45 years), tumor size ≤ 1 cm and disease progression.

Conclusions Increased expression of cytokines suggested correlation between inflammatory factors and progression of thyroid tumors.

Along with this, the balance between IL-17 A and FoxP3 may play an important role in PTC development, prognosis and future management.